Hodgkin's Disease
Showing 1 - 25 of >10,000
Hodgkin Disease Trial in France (Morphological and functional magnetic resonance imaging (MRI), Neuropsychological assessment)
Not yet recruiting
- Hodgkin Disease
- Morphological and functional magnetic resonance imaging (MRI)
- Neuropsychological assessment
-
Arras, France
- +3 more
Oct 31, 2023
Acute Lymphoblastic Leukemia, Hodgkin Disease, Allogeneic Stem Cell Transplantation Trial in Erlangen (Low-field magnetic
Recruiting
- Acute Lymphoblastic Leukemia
- +2 more
- Low-field magnetic resonance imaging
- +3 more
-
Erlangen, Bavaria, GermanyDepartment of Pediatrics and Adolescent Medicine
Oct 23, 2023
Non-Hodgkin's Lymphoma and Hodgkin's Disease
Recruiting
- Lymphoma, Non-Hodgkin
- Hodgkin's Disease
-
Stanford, CaliforniaStanford University School of Medicine
Sep 9, 2022
Hodgkin Lymphoma Trial in Cologne (Pembrolizumab)
Not yet recruiting
- Hodgkin Lymphoma
-
Cologne, Germany1st Department of Medicine, Cologne University Hospital
Sep 19, 2023
Classical Hodgkin Lymphoma, Non-Hodgkin Lymphoma Trial (GEN3017)
Not yet recruiting
- Classical Hodgkin Lymphoma
- Non-Hodgkin Lymphoma
- GEN3017
- (no location specified)
Aug 25, 2023
Resting Heart Rate and Heart Rate Variability in Survivors of
Active, not recruiting
- Hodgkin Disease
-
Memphis, TennesseeKirsten Ness
Jan 23, 2023
Cardiovascular Disease in Hodgkin Lymphoma Survivors
Not yet recruiting
- Hodgkin Lymphoma
- +3 more
- Patient Self Reporting
- +2 more
- (no location specified)
Jan 20, 2023
Hodgkin's Disease Trial in Boston (Echo/Stress Echo)
Active, not recruiting
- Hodgkin's Disease
- Echo/Stress Echo
-
Boston, Massachusetts
- +1 more
Mar 28, 2022
Classical Hodgkin Lymphoma Trial in Guangzhou (Zimberelimab 240mg)
Recruiting
- Classical Hodgkin Lymphoma
- Zimberelimab 240mg
-
Guangzhou, Guangdong, ChinaDepartment of Medical Oncology, Sun Yat-Sen University Cancer Ce
Jun 15, 2023
Hodgkin Lymphoma, Refractory Hodgkin Lymphoma, Relapsed Hodgkin's Disease, Adult Trial in Leon (Brentuximab Vedotin 50 MG
Recruiting
- Hodgkin Lymphoma
- +2 more
- Brentuximab Vedotin 50 MG [Adcetris]
-
Leon, Guanajuato, MexicoHospital Regional Alta Especialidad Bajio
Oct 24, 2022
Classic Hodgkin Lymphoma Trial (Concurrent penpulimab and AVD, Sequential penpulimab and AVD)
Not yet recruiting
- Classic Hodgkin Lymphoma
- Concurrent penpulimab and AVD
- Sequential penpulimab and AVD
- (no location specified)
Jul 10, 2023
Hodgkin Lymphoma Trial in Valhalla (Brentuximab Vedotin, Doxorubicin, Vincristine)
Active, not recruiting
- Hodgkin Lymphoma
- Brentuximab Vedotin
- +3 more
-
Valhalla, New YorkNew York Medical College
Sep 27, 2022
Quality of Life in Adult and Pediatric Nodular
Recruiting
- Nodular Lymphocyte-Predominant Hodgkin Lymphoma
-
Aurora, Colorado
- +1 more
Oct 27, 2023
Safety Issues, Efficacy, Self Trial in Monterrey (low dose nivolumab in combination with AVD)
Recruiting
- Safety Issues
- Efficacy, Self
- low dose nivolumab in combination with AVD
-
Monterrey, Nuevo Leon, MexicoHospital Universitario Dr Jose Eleuterio Gonzalez
Mar 6, 2023
Multiple Myeloma, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Charlottesville (Pre-biotic foods/drinks)
Completed
- Multiple Myeloma
- +11 more
- Pre-biotic foods/drinks
-
Charlottesville, VirginiaUniversity of Virginia
Jan 2, 2023
Hodgkin Lymphoma Trial in Houston (Brentuximab vedotin, Doxorubicin Hydrochloride, Pembrolizumab)
Not yet recruiting
- Hodgkin Lymphoma
- Brentuximab vedotin
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jun 20, 2023
Clinical, Laboratory and Epidemiologic Characterization of
Recruiting
- Waldenstrom Macroglobulinemia
- +4 more
-
Bethesda, Maryland
- +1 more
Jan 25, 2023
Relapsed or Refractory Hodgkin Lymphoma Trial in Beijing (SHR2554+ SHR1701, SHR-1701)
Recruiting
- Relapsed or Refractory Hodgkin Lymphoma
- SHR2554+ SHR1701
- SHR-1701
-
Beijing, Beijing, ChinaHan wei dong
Jun 14, 2023
Brazilian Prospective Hodgkin Lymphoma Registry
Recruiting
- Hodgkin Lymphoma
- Hodgkin Disease
-
Rio de Janeiro, BrazilUniversidade Federal Do Rio de Janeiro
May 16, 2022
Myocardial Injury in Hodgkin Lymphoma (HL) Survivors
Active, not recruiting
- Hodgkin Lymphoma Survivor
- Clinical Assessment
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Dec 22, 2022
Hodgkin Lymphoma Trial in Moscow (Nivolumab)
Recruiting
- Hodgkin Lymphoma
-
Moscow, Russian FederationThe Federal Budget-Funded Institution National Medical Surgical
Oct 31, 2022
Lung Cancer, Esophageal Cancer, Thoracic Cancer Trial in Saint Louis (Home-based cardiac rehabilitation)
Recruiting
- Lung Cancer
- +8 more
- Home-based cardiac rehabilitation
-
Saint Louis, MissouriWashington University School of Medicine
Aug 9, 2022
Recurrent/Refractory Classical Hodgkin's Lymphoma Trial in Tianjin (AK105,Anrotinib HCl)
Enrolling by invitation
- Recurrent/Refractory Classical Hodgkin's Lymphoma
- AK105,Anrotinib hydrochloride
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Insititute & Hospital
Jan 12, 2023